Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.10.2024MEDOCHEMIE Ltd. (MOE)93336Mabron Retard 200 (tbl plg 30x200 mg (blis.Al/PVC))14.10.2024O
 18.10.2024MEDOCHEMIE Ltd. (MOE)7675BSAGILIA 1mg tablety (tbl 100x1 mg (blis.PVC/PE/PVDC/Al))14.10.2024R
 18.10.2024MEDOCHEMIE Ltd. (MOE)0324DSOFENTIL 5 mikrogramov/ml injekčný/infúzny roztok (sol ijf 5x10 ml (amp.skl.))14.10.2024R
 18.10.2024MEDOCHEMIE Ltd. (MOE)0645DAPEL 600 mg filmom obalené tablety (tbl flm 10x600 mg (blis.PVC/PVDC/Al))14.10.2024R
 18.10.2024MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))14.10.2024R
 18.10.2024MEDOCHEMIE Ltd. (MOE)4778BAKTIPROL 200 mg tablety (tbl 60x200 mg (blis.PVC/PVDC/Al))14.10.2024R
 18.10.2024MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))14.10.2024R
 17.10.2024STADA Arzneimittel AG (STD)4103EBevimlar 15 mg filmom obalené tablety (tbl flm 42x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4099EBevimlar 15 mg filmom obalené tablety (tbl flm 28x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4109EBevimlar 15 mg filmom obalené tablety (tbl flm 98x15 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4089EBevimlar 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024STADA Arzneimittel AG (STD)4081EBevimlar 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/PVDC/Al))16.10.2024O
 17.10.2024Pfizer Europe MA EEIG (PFI-BE-3)93860DIFLUCAN 150 mg (cps dur 1x150 mg (blis.PVC/Al-priehľ.))31.10.2024R
 17.10.2024GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13975Flixotide 250 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))14.10.2024O
 16.10.2024STADA Arzneimittel AG (STD)5899EDabigatran-etexilát STADA Arzneimittel 150 mg tvrdé kapsuly (cps dur 180 (3x60x1) x150 mg (blis.Al/OPA/Al/PVC - jednotk.bal. - multibal.))16.10.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)